Append is a startup founded in 2022 based in Israel. Brouky records 1 investor associated with the company.
Append develops a novel implant-free transcatheter system for left atrial appendage (LAA) elimination that uses a vacuum-driven inversion and ligation technique. The approach aims to achieve LAA closure without leaving an implanted device, reducing risks like device-related thrombosis and peri-device leak.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.